01 March 2017
News and Views
Links and Services
A study in the latest issue of Alimentary Pharmacology & Therapeutics investigates resolution of adefovir-related nephrotoxicity by adefovir dose-reduction in patients with chronic hepatitis B.
Chronic hepatitis B patients treated with adefovir were followed up to evaluate nephrotoxicity an
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors